BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -1.13% -6.90% -17.54% 8.57% -3.39% -0.78% 0.46% -3.13% 14.45% 04/07/2010
BIB NAV -1.08% -7.11% -17.59% 8.57% -3.48% -0.81% 0.42% -3.14% 14.44% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 3/19/2025
  • NAV
    $53.54
  • NAV Change
    $+0.59 up caret
  • Market Price
    $53.63
  • Market Price Change
    $+0.58 up caret
  • Trading Volume (M)
    8,725
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 3/19/2025
  • NAV
    $53.54
  • NAV Change
    $+0.59 up caret
  • Market Price
    $53.63
  • Market Price Change
    $+0.58 up caret
  • Trading Volume (M)
    8,725
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 12/31/2024

Holdings

as of 3/19/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
7.25% GILD GILEAD SCIENCES INC -- $4,345,769.22 40,422 2369174
6.97% AMGN AMGEN INC -- $4,178,319.75 13,233 2023607
6.83% VRTX VERTEX PHARMACEUTICALS INC -- $4,097,084.88 7,994 2931034
5.24% REGN REGENERON PHARMACEUTICALS -- $3,142,610.64 4,674 2730190
3.21% AZN ASTRAZENECA PLC-SPONS ADR -- $1,922,577.12 25,191 2989044
2.36% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,414,702.08 5,582 B00FWN1
1.49% BIIB BIOGEN INC -- $891,009.00 6,300 2455965
1.44% ARGX ARGENX SE - ADR -- $864,238.18 1,394 BDVLM39
1.27% SNY SANOFI-ADR -- $763,089.20 13,022 2964557
1.07% RPRX ROYALTY PHARMA PLC- CL A -- $641,973.15 19,215 BMVP7Y0
1.07% SMMT SUMMIT THERAPEUTICS INC -- $641,408.45 31,895 BMTVQS7
1.03% UTHR UNITED THERAPEUTICS CORP -- $615,699.35 1,931 2430412
1.02% INSM INSMED INC -- $610,837.72 7,738 2614487
1.01% ITCI INTRA-CELLULAR THERAPIES INC -- $602,933.52 4,584 BHCB0P4
0.98% BMRN BIOMARIN PHARMACEUTICAL INC -- $587,890.76 8,243 2437071
0.97% ILMN ILLUMINA INC -- $582,740.64 6,859 2613990
0.93% MRNA MODERNA INC -- $554,711.36 16,648 BGSXTS3
0.85% ONC BEIGENE LTD-ADR -- $510,154.16 1,916 BYYWPW6
0.84% INCY INCYTE CORP -- $502,813.22 8,333 2471950
0.81% VTRS VIATRIS INC -- $486,298.08 51,624 BMWS3X9
0.81% NBIX NEUROCRINE BIOSCIENCES INC -- $483,157.80 4,380 2623911
0.76% EXEL EXELIXIS INC -- $457,839.24 12,354 2576941
0.74% MEDP MEDPACE HOLDINGS INC -- $441,429.56 1,348 BDCBC61
0.72% ASND ASCENDIS PHARMA A/S - ADR -- $433,224.45 2,609 BV9G6B8
0.70% BNTX BIONTECH SE-ADR -- $421,698.96 4,248 BK6H543
0.68% PCVX VAXCYTE INC -- $410,546.88 5,392 BKPVGH6
0.62% JAZZ JAZZ PHARMACEUTICALS PLC -- $371,655.12 2,616 B4Q5ZN4
0.59% HALO HALOZYME THERAPEUTICS INC -- $354,164.40 5,508 2975098
0.57% ROIV ROIVANT SCIENCES LTD -- $344,445.90 31,485 BMW4NZ9
0.55% SRPT SAREPTA THERAPEUTICS INC -- $330,196.13 4,129 B8DPDT7
0.54% MDGL MADRIGAL PHARMACEUTICALS INC -- $321,005.34 942 BD59BS7
0.53% TEM TEMPUS AI INC -- $316,613.76 6,592 BSLSJJ0
0.47% RVMD REVOLUTION MEDICINES INC -- $281,867.50 7,274 BL71K91
0.46% BBIO BRIDGEBIO PHARMA INC -- $275,940.00 8,176 BK1KWG8
0.44% AXSM AXSOME THERAPEUTICS INC -- $263,760.50 2,095 BYZR4X4
0.41% BPMC BLUEPRINT MEDICINES CORP -- $248,277.12 2,744 BWY52P3
0.41% GH GUARDANT HEALTH INC -- $247,060.32 5,343 BFXC911
0.40% ALKS ALKERMES PLC -- $240,276.98 6,997 B3P6D26
0.39% KRYS KRYSTAL BIOTECH INC -- $235,718.28 1,246 BD6JX35
0.38% IONS IONIS PHARMACEUTICALS INC -- $227,645.52 6,828 BDJ0LS6
0.37% CYTK CYTOKINETICS INC -- $221,638.45 5,101 BBBSBJ5
0.37% NUVL NUVALENT INC-A -- $219,910.95 2,835 BMVBZD3
0.35% VRNA VERONA PHARMA PLC - ADR -- $211,488.00 3,200 BYWPZK5
0.35% ADMA ADMA BIOLOGICS INC -- $210,716.64 10,224 B9NSBM2
0.32% PTCT PTC THERAPEUTICS INC -- $190,085.28 3,336 B17VCN9
0.28% ACLX ARCELLX INC -- $166,744.95 2,337 BPCJ1Q2
0.27% RNA AVIDITY BIOSCIENCES INC -- $163,802.08 5,164 BMWHPY1
0.27% SWTX SPRINGWORKS THERAPEUTICS INC -- $163,028.60 3,220 BGMGM89
0.26% RARE ULTRAGENYX PHARMACEUTICAL IN -- $158,521.60 3,995 BJ62Z18
0.26% CRSP CRISPR THERAPEUTICS AG -- $154,800.54 3,691 BDHF4K6
0.24% RYTM RHYTHM PHARMACEUTICALS INC -- $146,527.34 2,654 BF2YWG4
0.23% PTGX PROTAGONIST THERAPEUTICS INC -- $139,896.90 2,574 BDCBCD8
0.23% MRUS MERUS NV -- $139,308.00 2,964 BZBY005
0.23% CRNX CRINETICS PHARMACEUTICALS IN -- $139,096.04 4,012 BDD19F8
0.23% SRRK SCHOLAR ROCK HOLDING CORP -- $137,782.32 4,056 BFZQ0L8
0.23% AKRO AKERO THERAPEUTICS INC -- $135,146.04 3,018 BK7Y2V9
0.22% LEGN LEGEND BIOTECH CORP-ADR -- $134,536.64 3,533 BMX9K07
0.22% APLS APELLIS PHARMACEUTICALS INC -- $133,477.80 5,380 BYTQ6X1
0.22% ALVO ALVOTECH SA -- $130,897.62 11,543 BPNTJ34
0.21% ACAD ACADIA PHARMACEUTICALS INC -- $124,384.26 7,194 2713317
0.20% IMVT IMMUNOVANT INC -- $119,888.00 6,350 BJRFSB7
0.20% FOLD AMICUS THERAPEUTICS INC -- $118,900.80 12,924 B19FQ48
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $117,025.65 13,405 BFNF1D6
0.19% XENE XENON PHARMACEUTICALS INC -- $115,302.00 3,300 BRJ3GY4
0.18% RXRX RECURSION PHARMACEUTICALS-A -- $108,668.70 16,515 BM9FJ13
0.18% TWST TWIST BIOSCIENCE CORP -- $107,002.20 2,566 BGKG6G7
0.18% VCYT VERACYTE INC -- $106,463.00 3,350 BFTWZY0
0.17% VCEL VERICEL CORP -- $101,263.05 2,135 BSBMN89
0.17% EWTX EDGEWISE THERAPEUTICS INC -- $100,720.64 4,096 BKY5JZ8
0.16% MIRM MIRUM PHARMACEUTICALS INC -- $97,889.01 2,077 BJDX8Y8
0.16% KYMR KYMERA THERAPEUTICS INC -- $95,005.35 2,805 BMPRZV5
0.16% -- NEWAMSTERDAM PHARMA CO NV -- $94,321.95 3,995 BP8JSP4
0.15% DNLI DENALI THERAPEUTICS INC -- $92,254.50 6,225 BD2B4V0
0.15% NVCR NOVOCURE LTD -- $90,417.60 4,680 BYSS4X4
0.15% LGND LIGAND PHARMACEUTICALS -- $88,368.54 818 2501578
0.14% ZLAB ZAI LAB LTD-ADR -- $85,674.54 2,254 BD9GVY0
0.14% HRMY HARMONY BIOSCIENCES HOLDINGS -- $84,968.00 2,470 BKSGZN7
0.14% BEAM BEAM THERAPEUTICS INC -- $84,654.84 3,581 BK6L288
0.14% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $84,079.00 5,065 BKX9VD3
0.14% ARWR ARROWHEAD PHARMACEUTICALS IN -- $83,259.54 5,382 BYQBFJ8
0.14% IBRX IMMUNITYBIO INC -- $83,194.68 30,143 BNSP0B8
0.14% TARS TARSUS PHARMACEUTICALS INC -- $81,955.70 1,654 BMH5RL1
0.14% CGON CG ONCOLOGY INC -- $81,931.69 2,923 BRBCSP4
0.13% APGE APOGEE THERAPEUTICS INC -- $78,817.56 1,949 BM9HHL5
0.13% AGIO AGIOS PHARMACEUTICALS INC -- $78,249.60 2,470 BCBVTX1
0.13% DVAX DYNAVAX TECHNOLOGIES CORP -- $77,488.84 5,681 BRJZSK0
0.13% TVTX TRAVERE THERAPEUTICS INC -- $76,817.70 3,711 BLFGJD5
0.13% SUPN SUPERNUS PHARMACEUTICALS INC -- $76,519.67 2,389 B72ZBG4
0.13% VERA VERA THERAPEUTICS INC -- $75,731.80 2,734 BL55460
0.12% JANX JANUX THERAPEUTICS INC -- $70,165.70 2,270 BMFX8Y7
0.12% IRON DISC MEDICINE INC -- $69,109.64 1,286 BMGJZJ8
0.11% BCRX BIOCRYST PHARMACEUTICALS INC -- $68,349.54 8,958 2100362
0.11% IDYA IDEAYA BIOSCIENCES INC -- $68,087.19 3,739 BK0VHF6
0.11% WVE WAVE LIFE SCIENCES LTD -- $66,243.92 6,598 BYZG9R0
0.11% CNTA CENTESSA PHARMACEUTICALS-ADR -- $64,732.20 3,860 BLB0YQ9
0.11% MNKD MANNKIND CORP -- $63,313.32 11,901 BF081J4
0.10% ANIP ANI PHARMACEUTICALS INC -- $59,096.57 911 BCDWBX6
0.10% INDV INDIVIOR PLC -- $58,685.10 5,898 BP0BQQ5
0.10% GPCR STRUCTURE THERAPEUTICS INC -- $58,072.61 2,573 BQS9486
0.10% AMPH AMPHASTAR PHARMACEUTICALS IN -- $57,976.66 2,081 BNFWZS4
0.09% ARDX ARDELYX INC -- $54,999.54 10,242 BN89V40
0.09% NVAX NOVAVAX INC -- $54,879.58 6,938 BJDQXG4
0.09% DYN DYNE THERAPEUTICS INC -- $54,572.40 4,401 BN15WD1
0.09% OCUL OCULAR THERAPEUTIX INC -- $52,375.40 6,802 BNZB1X8
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $51,835.41 6,193 BFWLC09
0.08% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $49,151.52 1,712 BLCD809
0.08% SPRY ARS PHARMACEUTICALS INC -- $48,964.95 4,203 BMCR7V2
0.08% PCRX PACIRA BIOSCIENCES INC -- $48,511.44 1,998 B3X26D8
0.08% SNDX SYNDAX PHARMACEUTICALS INC -- $48,425.92 3,691 BN7Q7R7
0.08% ADPT ADAPTIVE BIOTECHNOLOGIES -- $48,247.92 6,382 BJ5FZ74
0.08% TXG 10X GENOMICS INC-CLASS A -- $47,622.12 4,628 BKS3RS7
0.08% IOVA IOVANCE BIOTHERAPEUTICS INC -- $46,920.80 13,180 BF0DMK7
0.08% INVA INNOVIVA INC -- $46,855.90 2,710 BDDXF67
0.08% SYRE SPYRE THERAPEUTICS INC -- $46,736.00 2,540 BQBBDY8
0.07% ETNB 89BIO INC -- $44,714.73 5,087 BK1K484
0.07% GERN GERON CORP -- $44,453.30 26,149 2370381
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $44,182.35 2,115 BMFD115
0.07% GRFS GRIFOLS SA-ADR -- $42,824.88 5,274 B8K7T65
0.07% NRIX NURIX THERAPEUTICS INC -- $42,603.50 3,065 BMVLGP2
0.07% HROW HARROW INC -- $42,011.20 1,540 BHNDW86
0.07% COLL COLLEGIUM PHARMACEUTICAL INC -- $41,610.90 1,394 BX7RSN3
0.07% KNSA KINIKSA PHARMACEUTICALS INTE -- $41,497.84 1,798 BRXB0C0
0.07% VIR VIR BIOTECHNOLOGY INC -- $41,387.25 5,955 BK4PZ38
0.07% NTLA INTELLIA THERAPEUTICS INC -- $40,966.50 4,405 BYZM6C2
0.07% GRAL GRAIL INC -- $40,670.52 1,452 BSLSSX7
0.07% XNCR XENCOR INC -- $39,774.78 3,027 BGCYWN8
0.06% REPL REPLIMUNE GROUP INC -- $38,272.00 3,328 BDDVW37
0.06% ZYME ZYMEWORKS INC -- $38,114.20 2,980 BPCQZY9
0.06% EOLS EVOLUS INC -- $36,826.98 2,734 BDRJH21
0.06% GMAB GENMAB A/S -SP ADR -- $36,713.25 1,813 BBC9WC7
0.06% AVDL AVADEL PHARMACEUTICALS -- $36,544.59 4,167 BDGMC59
0.06% MLYS MINERALYS THERAPEUTICS INC -- $36,180.00 2,160 BP9N0G0
0.06% DAWN DAY ONE BIOPHARMACEUTICALS I -- $36,133.92 4,364 BLB0YH0
0.06% AVXL ANAVEX LIFE SCIENCES CORP -- $36,083.28 3,667 BYTYP72
0.06% FTRE FORTREA HOLDINGS INC -- $35,901.02 3,877 BRXYZ57
0.06% XERS XERIS BIOPHARMA HOLDINGS INC -- $35,528.48 6,448 BLR7H87
0.06% COGT COGENT BIOSCIENCES INC -- $35,270.76 4,776 BLR6XK8
0.06% RCKT ROCKET PHARMACEUTICALS INC -- $33,374.70 3,945 BDFKQ07
0.05% PRAX PRAXIS PRECISION MEDICINES I -- $31,127.72 806 BQ721R4
0.05% ABCL ABCELLERA BIOLOGICS INC -- $30,529.86 12,774 BL53SR3
0.05% LENZ LENZ THERAPEUTICS INC -- $30,292.24 1,187 BQV0J03
0.05% PRTA PROTHENA CORP PLC -- $29,933.12 2,324 B91XRN2
0.05% QURE UNIQURE NV -- $29,610.36 2,109 BJFSR88
0.05% CVAC CUREVAC NV -- $29,497.12 9,703 BN4RD42
0.05% CRMD CORMEDIX INC -- $28,818.19 2,627 BJ0LT31
0.05% AVBP ARRIVENT BIOPHARMA INC -- $28,557.20 1,457 BMGTLY5
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $27,145.31 8,201 BZ0QMB7
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $26,278.14 3,382 BFYQFJ2
0.04% ARVN ARVINAS INC -- $25,891.20 2,976 BDZ30Q0
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $25,506.80 2,108 BD06CS0
0.04% CSTL CASTLE BIOSCIENCES INC -- $24,894.48 1,212 BKLCWZ3
0.04% KURA KURA ONCOLOGY INC -- $24,449.01 3,363 BYZD465
0.04% TYRA TYRA BIOSCIENCES INC -- $24,429.24 2,189 BMVNDH9
0.04% RLAY RELAY THERAPEUTICS INC -- $24,184.94 7,241 BN2R582
0.04% ORIC ORIC PHARMACEUTICALS INC -- $22,820.85 3,055 BKVDFF7
0.04% PGEN PRECIGEN INC -- $22,673.93 12,667 BKM5C84
0.04% TRVI TREVI THERAPEUTICS INC -- $22,629.63 3,323 BJH9ZN0
0.04% SANA SANA BIOTECHNOLOGY INC -- $22,602.06 9,659 BMFJJ97
0.04% OMER OMEROS CORP -- $22,485.92 2,504 B4NB858
0.04% CGEM CULLINAN THERAPEUTICS INC -- $21,780.70 2,518 BM90J52
0.04% HCM HUTCHMED CHINA-ADR -- $21,762.10 1,345 BYXV9H7
0.04% ANAB ANAPTYSBIO INC -- $21,635.04 1,316 BDRW1L7
0.04% VERV VERVE THERAPEUTICS INC -- $21,563.29 3,661 BNKGXX2
0.04% SVRA SAVARA INC -- $21,449.58 7,422 BYXGN81
0.04% SAGE SAGE THERAPEUTICS INC -- $21,367.06 2,651 BP4GNK9
0.04% URGN UROGEN PHARMA LTD -- $21,291.16 1,826 BZ7PJQ1
0.04% MNMD MIND MEDICINE MINDMED INC -- $21,232.30 3,169 BPQYY97
0.03% TBPH THERAVANCE BIOPHARMA INC -- $20,133.22 2,126 BMNDK09
0.03% KROS KEROS THERAPEUTICS INC -- $20,030.68 1,754 BM7V485
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $19,628.68 881 BL95N25
0.03% STOK STOKE THERAPEUTICS INC -- $18,948.44 2,294 BJQ05Z6
0.03% MESO MESOBLAST LTD- SPON ADR -- $18,725.82 1,383 BQS7491
0.03% EYPT EYEPOINT PHARMACEUTICALS INC -- $18,495.72 2,988 BMGS7L1
0.03% HUMA HUMACYTE INC -- $18,426.77 5,567 BMYTJP4
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $18,364.50 2,310 BLFBZ32
0.03% TRML TOURMALINE BIO INC -- $18,243.36 1,107 BQ80NC6
0.03% RGNX REGENXBIO INC -- $18,224.00 2,144 BZ0G875
0.03% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $18,173.65 1,903 BKDQKM6
0.03% ERAS ERASCA INC -- $18,098.92 12,229 BNLYBF3
0.03% PHAT PHATHOM PHARMACEUTICALS INC -- $17,990.72 2,959 BJLKVS6
0.03% ALT ALTIMMUNE INC -- $17,871.56 3,076 BFY7DC4
0.03% GLUE MONTE ROSA THERAPEUTICS INC -- $17,775.10 2,653 BP7KZP7
0.03% SIGA SIGA TECHNOLOGIES INC -- $17,707.90 3,085 2107437
0.03% ORKA ORUKA THERAPEUTICS INC -- $17,607.82 1,514 BKVF0J2
0.03% TRDA ENTRADA THERAPEUTICS INC -- $17,372.00 1,616 BP81RK8
0.03% RNAC CARTESIAN THERAPEUTICS INC -- $17,006.00 1,100 BQB9HM8
0.03% AUTL AUTOLUS THERAPEUTICS PLC -- $16,749.96 8,634 BFMLGR4
0.03% TSHA TAYSHA GENE THERAPIES INC -- $16,222.95 8,865 BNC1BX1
0.03% AURA AURA BIOSCIENCES INC -- $16,185.89 2,161 BP81R42
0.03% GLPG GALAPAGOS NV-SPON ADR -- $15,816.60 606 B292NQ7
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $15,691.40 1,171 BKC9SX3
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $15,595.72 763 BQD3J33
0.03% RAPP RAPPORT THERAPEUTICS INC -- $15,491.52 1,584 BR3T9B6
0.03% ATXS ASTRIA THERAPEUTICS INC -- $15,402.71 2,441 BMYRFN8
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $15,323.23 9,067 BFZNYB7
0.02% MXCT MAXCYTE INC -- $14,914.47 4,561 BKMQF66
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $14,905.62 6,134 BMCWKZ2
0.02% ABSI ABSCI CORP -- $14,804.64 4,968 BN94K69
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $14,803.75 11,843 B4N8MH9
0.02% ESPR ESPERION THERAPEUTICS INC -- $14,238.42 8,526 BBNBTD2
0.02% TECX TECTONIC THERAPEUTIC INC -- $13,984.96 638 BPBPCG8
0.02% OABI OMNIAB INC -- $13,301.98 5,237 BN13S71
0.02% TKNO ALPHA TEKNOVA INC -- $13,098.08 2,306 BP7L561
0.02% VNDA VANDA PHARMACEUTICALS INC -- $12,458.68 2,522 B12W3P6
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $12,287.60 2,780 BYP80F1
0.02% SLRN ACELYRIN INC -- $12,105.81 4,339 BQPF874
0.02% DSGN DESIGN THERAPEUTICS INC -- $11,833.50 2,450 BMFK3H6
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $11,759.08 3,946 BYVQJ96
0.02% TERN TERNS PHARMACEUTICALS INC -- $11,609.84 3,674 BMDJ0C9
0.02% AVIR ATEA PHARMACEUTICALS INC -- $11,583.18 3,654 BLN9Z50
0.02% ANNX ANNEXON INC -- $11,530.00 4,612 BMVV9R5
0.02% PRME PRIME MEDICINE INC -- $11,348.00 5,674 BPBJFM7
0.02% PSNL PERSONALIS INC -- $11,226.53 3,059 BJQ0608
0.02% TSVT 2SEVENTY BIO INC -- $11,060.80 2,230 BMTXV88
0.02% ITOS ITEOS THERAPEUTICS INC -- $11,010.72 1,582 BMWXFT4
0.02% AMLX AMYLYX PHARMACEUTICALS INC -- $10,833.20 2,968 BPCK358
0.02% FHTX FOGHORN THERAPEUTICS INC -- $10,673.76 2,404 BMF7DT9
0.02% IRWD IRONWOOD PHARMACEUTICALS INC -- $10,312.29 6,921 B3MZ6K5
0.02% OLMA OLEMA PHARMACEUTICALS INC -- $10,188.69 2,479 BMZ4LN0
0.02% NGNE NEUROGENE INC -- $9,915.06 643 BS2F741
0.02% VYGR VOYAGER THERAPEUTICS INC -- $9,668.76 2,364 BY7RB53
0.02% ACIU AC IMMUNE SA -- $9,501.60 4,280 BZC0D70
0.02% YMAB Y-MABS THERAPEUTICS INC -- $9,496.20 1,938 BG31GH0
0.02% CDXS CODEXIS INC -- $9,357.88 3,518 B5LL2C2
0.01% ALMS ALUMIS INC -- $8,923.54 2,042 BPLQG36
0.01% INBX INHIBRX BIOSCIENCES INC -- $8,778.00 627 BNSP8K3
0.01% TVGN TEVOGEN BIO HOLDINGS INC -- $8,632.08 7,572 BPG5P75
0.01% NMRA NEUMORA THERAPEUTICS INC -- $8,521.70 6,985 BN4JN37
0.01% SLDB SOLID BIOSCIENCES INC -- $8,324.14 1,727 BQHN6C7
0.01% CRGX CARGO THERAPEUTICS INC -- $8,262.65 1,991 BQHN2F2
0.01% TNGX TANGO THERAPEUTICS INC -- $8,012.63 4,645 BP2P6L0
0.01% AMRN AMARIN CORP PLC -ADR -- $7,962.60 17,310 2301938
0.01% SLN SILENCE THERAPEUTICS PLC-ADR -- $7,688.52 2,034 BL5B6Z1
0.01% FDMT 4D MOLECULAR THERAPEUTICS IN -- $7,576.21 1,999 BKLXFX5
0.01% ACRV ACRIVON THERAPEUTICS INC -- $7,332.78 1,343 BP2TPK4
0.01% LRMR LARIMAR THERAPEUTICS INC -- $7,088.06 2,758 BMXNGZ6
0.01% LYEL LYELL IMMUNOPHARMA INC -- $7,025.82 12,076 BN6MB18
0.01% THRD THIRD HARMONIC BIO INC -- $6,887.03 1,951 BNNPQY8
0.01% CMPS COMPASS PATHWAYS PLC -- $6,735.06 2,201 BMC3HS7
0.01% SCPH SCPHARMACEUTICALS INC -- $6,569.44 2,161 BYX2Z16
0.01% CCCC C4 THERAPEUTICS INC -- $6,539.84 3,056 BKX9NQ0
0.01% MGNX MACROGENICS INC -- $5,925.24 2,718 BFDV8K0
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $5,899.04 916 B9L5200
0.01% ALEC ALECTOR INC -- $5,633.88 4,236 BJ4LDC4
0.01% LXRX LEXICON PHARMACEUTICALS INC -- $5,589.16 15,634 BWFZX59
0.01% EDIT EDITAS MEDICINE INC -- $4,963.69 3,571 BZ8FPH3
0.01% ARTV ARTIVA BIOTHERAPEUTICS INC -- $4,670.88 1,052 BMF1LJ7
0.01% NKTX NKARTA INC -- $4,643.60 3,055 BK80YJ8
0.01% FATE FATE THERAPEUTICS INC -- $4,513.51 4,984 BCZS820
0.01% KYTX KYVERNA THERAPEUTICS INC -- $4,420.05 1,865 BSMLR16
0.01% LXEO LEXEO THERAPEUTICS INC -- $4,398.88 1,447 BQ6C357
0.01% BMEA BIOMEA FUSION INC -- $4,277.91 1,567 BNKF6N0
0.01% PLRX PLIANT THERAPEUTICS INC -- $4,268.70 2,635 BMDWW66
0.01% CLYM CLIMB BIO INC -- $3,919.05 2,903 BMW5LX6
0.01% TCRX TSCAN THERAPEUTICS INC -- $3,614.20 2,126 BNLYBJ7
-- STRO SUTRO BIOPHARMA INC -- $2,927.79 3,567 BF12XC2
-- PEPG PEPGEN INC -- $2,850.22 1,411 BMTX3D7
-- INZY INOZYME PHARMA INC -- $2,775.67 2,779 BMVLGY1
-- OKUR ONKURE THERAPEUTICS INC-A -- $2,765.00 553 BT7KGT6
-- PYXS PYXIS ONCOLOGY INC -- $2,746.69 2,567 BLBR8D5
-- APLT APPLIED THERAPEUTICS INC -- $2,563.29 5,031 BJL38Z1
-- MRSN MERSANA THERAPEUTICS INC -- $2,451.98 5,342 BF3NP05
-- IGMS IGM BIOSCIENCES INC -- $1,870.71 1,473 BKS3SM8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- QTTB Q32 BIO INC -- $1,144.80 530 BS2FKQ4
41.41% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 24,827,124 -- 5,560 --
35.60% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 21,344,182 -- 4,780 --
21.85% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 13,101,220 -- 2,934 --
9.84% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,898,675 -- 1,321 --
9.36% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 5,612,895 -- 1,257 --
7.07% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 4,242,045 -- 950 --
-- -- TREASURY BILL -- $9,985,916.70 10,000,000 BTBKBR5
-- -- NET OTHER ASSETS (LIABILITIES) -- $5,274,058.67 5,274,059 --

Index

as of 12/31/2024

  • Total Number of Companies265
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.58 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.